She Came to Think, Not Just to Be Smart: A Conversation with Dr. Denise Bronner
There's a difference between intelligence and curiosity. A lot of people have one and mistake it for the other. Dr. Denise Bronner has both, and she knows exactly what to do with them.
A Detroit girl with a Wayne State undergraduate degree and a PhD from the University of Michigan, Dr. Bronner built a career that most people would need two lifetimes to construct. Fifteen years of experience spanning organizational thought leadership, healthcare, pharma, consulting, and venture capital. A consulting practice named Impactful Adventures that she built on the conviction that representation in clinical trials isn't a moral checkbox. It's a business imperative. She is one of the Dope Thinkers to Watch for 2026, and sitting down with her for this conversation confirmed exactly why.
From the jump, Dr. Bronner set the tone: "Dr. Denise Bronner is a kid who never runs out of curiosity." No rehearsed elevator pitch. No credential-stacking. Just a woman who loves sports, anime, Legos, and can walk into a room full of strangers and walk out with something. That's not a personality quirk — that's a superpower. And it shows up everywhere in how she thinks.
DEI Wasn't the Problem. The Execution Was.
When the conversation turned to the dismantling of DEI initiatives across pharma and corporate America, Dr. Bronner didn't flinch. She also didn't get preachy. She got precise.
"DEI wasn't the problem. It's the way pharma did it."
The mistake, she argued, was tethering diversity entirely to altruism. For years, the industry made a moral case for inclusion without building the economic one. When budgets tightened and political winds shifted, there was no business firewall to protect the work. "When it got to the point where they were starting to push back and they're like, prove it, show me some metrics — we saw that with a lot of vendors who were being pushed hard on how are you tying this back to what I care about?"
That failure has real consequences. And she's not interested in pretending otherwise. "It's a little too late as far as I'm concerned." Not cynicism — just honesty. Honesty is the first step toward fixing it properly this time.
Health and Care Are Not the Same Word
One of the sharpest distinctions in the conversation came when Kulur Group CEO, Nicholas Love reframed the conversation by separating two terms that healthcare has collapsed into one. Health — a state of physical, mental, and social well-being — and care — the active practice of maintaining and improving that state — are distinct. And treating them as interchangeable has cost people their lives.
Dr. Bronner built on this with numbers that should stop anyone cold.
73% of Black women who work in the healthcare industry itself had never been asked to participate in a clinical trial. In some psoriasis trials, white patients represented up to 90% of participants. Dermatology training images showing skin of color? Just 14%.
"I have never seen psoriasis on someone with your skin tone." That sentence, coming from a dermatologist in 2025, is not a relic of the past. It is an active present-tense failure baked into the system.
The structural barriers are layered: assumptions about which communities are "too difficult" to recruit, doctors who don't mention trials because they don't have 30 minutes to explain them, incentive structures designed for speed and volume rather than depth. 80% of patients say they didn't know a clinical trial was even an option — because no one told them.
"That requires a longer conversation. And doctors are told to get in and out quick, quick, quick, quick."
The Doctor Who Changed the Room
Here's where Dr. Bronner got personal, and where the conversation became something different.
Her father, a man who "absolutely hates doctors, can't stand them," was sitting closed off in an exam room. His oncologist walked in, and instead of jumping to the diagnosis, he said: Before you talk, let me tell you what I read in your records.
He went through everything. Every detail. Then asked: Did I miss anything?
"That changed the entire aura in that room."
Later, when her father was struggling with chemo side effects, the same doctor said plainly: I'm not taking it, you are. If you don't want to do this, you've got to let me know. He was transparent about the stakes. He was listening. He was doing the emotional labor that we almost never honor or protect in our physicians.
"Are we doing right by them by providing the resources and support and care that they need? I don't think we're doing enough for our doctors."
It's a both/and problem. Patients deserve to be heard. Doctors deserve to be sustained. The current system is failing both — and calling it efficiency.
AI and the Question Nobody's Asking
Dr. Bronner is not afraid of AI in medicine. She's afraid of the shortcuts we'll take to deploy it.
In an ideal world? Digital simulations of clinical trials. Personalized medicine calibrated from wearables, behavioral data, social listening paint a more complete picture of a human being than any single intake form could ever provide. A future where we move from treating symptoms to understanding systems.
But the bias problem doesn't disappear when you wrap it in an algorithm. If the training data reflects a world where Black patients were undertreated and underrepresented, the model learns that world as normal. "You're going to still have the same type of bias baked into the system."
She also raised the question no one in the room had thought to ask: Who has final say? If AI flags a concern that the doctor dismissed, if the patient said something the model heard as critical, and the physician moved past it then who's accountable? "We already know how doctors can misdiagnose people. And if AI found it and said, "I don't think this is right, we need to escalate because there is a disconnect."
Transparency and ethics is the conversation that we need to be having right now, before we automate the wrong assumptions at scale.
What She Does Most with Love
At the close, Nicholas asked her the question that ends every With Love conversation: What do you do the most with love?
"I try to live my life with love and laughter. Those two I think are the most important. When I see people that are down, I try to cheer them up, and that's my love language, trying to do it through laughter. So I would just say living and laughing are probably the two things I do with love. I really care about people. That's my thing."
That's what makes Dr. Denise Bronner a dope thinker. Not just the PhD. Not just the receipts, and there are receipts. It's that she walks into rooms curious, leaves them better than she found them, and connects the dots between science and story, data and dignity, health and care in a way that actually moves the needle.
We define dope thinkers as people who elevate categories, products, and culture to the power of diverse and inclusive intelligence.
Dr. Denise Bronner fits the bill to a T.
Dr. Denise Bronner is the founder and CEO of Impactful Adventures, a consulting firm working with pharma startups and founders to improve clinical trial diversity and access. She is one of the Dope Thinkers to Watch for 2026.
Connect with her work at Impactful Adventures and follow her across platforms for more on health equity, pharma innovation, and the intersection of data and human care.